Skip to main content
. 2020 Apr 6;11(13):3944–3954. doi: 10.7150/jca.41733

Table 1.

Clinical characteristics of the subjects in the training set and validation sets.

Training set(n=160) validation set(n=150)
case control p case control p
number 80 80 60 90
Anthropometric characteristics
age (years) 59.40±8.08 51.45±5.55 <0.0001 60.43±8.14 51.58±8.03 <0.0001
gender (M/F) 53/27 45/35 0.194 41/19 52/38 0.192
BMI (kg/m2) 22.74±2.93 24.71±3.40 <0.0001 21.89±3.35 25.14±3.38 <0.0001
Blood Parameters
WBC (10^9/L) 6.25±1.83 6.24±1.63 0.9632 6.15±1.99 6.39±1.44 0.391
Hb (g/L) 133.52±13.25 145.27±14.88 <0.0001 130.44±13.44 148.31±14.01 <0.0001
PLT (10^9/L) 205.16±56.58 233.55±51.52 0.0012 206.02±55.73 239.64±53.35 0.0003
TNM stages
High-grade dysplasia 5 5
23 16
ⅠⅠ 31 24
ⅠⅠⅠ 19 11
IV 2 4

Unpaired t tests for continuous measures and χ2 tests for categorical variables. Abbreviations: BMI, body mass index; WBC, white blood cell; Hb, hemoglobin; PLT, platelet count.